[Erratum to: Ocrelizumab for treatment of multiple sclerosis]

Nervenarzt. 2020 Aug;91(8):735-736. doi: 10.1007/s00115-020-00956-3.
[Article in German]
No abstract available

Publication types

  • Published Erratum